Making it in Manufacturing Titelbild

Making it in Manufacturing

Making it in Manufacturing

Von: ARTO Talent
Jetzt kostenlos hören, ohne Abo

Nur 0,99 € pro Monat für die ersten 3 Monate

Danach 9.95 € pro Monat. Bedingungen gelten.

Über diesen Titel

Hosted by Thomas McMann, Making It In Manufacturing is ARTO's new in-person podcast series, spotlighting the leaders shaping the future of manufacturing and engineering.


Each episode dives into the careers, decisions, and defining moments of industry mainstays - revealing the stories and insights behind real-world impact within the manufacturing and engineering space.


If you're a leader in the space - or aspiring to be - this podcast is a must watch. The series is available on YouTube, Spotify, Apple Podcasts and all major platforms.


Hosted on Acast. See acast.com/privacy for more information.

ARTO Talent
Erfolg im Beruf Hygiene & gesundes Leben Wissenschaft Ökonomie
  • What Makes a CDMO Investable? Ankit Gupta on Building Instapill for Long-Term Growth
    Jan 16 2026
    The CDMO Changing the Game in Drug DeliveryThis week, in another episode of the Making it in Manufacturing Spotlight Series, we sit down with Ankit Gupta, CEO of Instapill, a company redefining oral drug delivery through freeze-dried, fast-dissolving tablets.With over 15 years of experience spanning investment banking, M&A, and leadership roles in pharmaceutical manufacturing, Ankit brings a sharp perspective on scaling, innovation, and sustainable differentiation.In this episode, Ankit covers:Instapill’s unique FDA-approved non-gelatin ODT technology and why it’s transforming patient outcomes in paediatrics and geriatrics.Scaling up manufacturing capacity in India and future expansion plans into the US, and how automation will maintain quality at scale.How digital transformation and AI are shaping pharmaceutical manufacturing, from paperless R&D to data-driven precision in production.What makes a CDMO attractive to investors, and how sustainable differentiation trumps trend-driven momentum.Lessons from M&A and investment banking, and how they inform his approach as a CEO leading growth in a competitive CDMO landscape.Be sure to check out this episode to hear how Instapill is not only innovating formulation, but reimagining the future of pharma manufacturing.To listen to (or watch) the full episode, search "Making it in Manufacturing Instapill" on your preferred streaming platform. Or, click on the first link in the comments below.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalent/Spotify: https://open.spotify.com/show/0kEcRZO...Instagram: https://www.instagram.com/arto.talent...TikTok: https://www.tiktok.com/@artotalent?_t...Apple Podcasts: https://podcasts.apple.com/us/podcast...Website: https://arto-talent.comYoutube: https://www.youtube.com/@life_sciencesAnkit GuptaCEO at InstapillLinkedIn: https://www.linkedin.com/in/reachankit/Thomas McMannDirector - Contracts DivisionLinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/Timestamps:00:11 Stand Out FDA Approval & Speed to Market08:00 Global Growth and Operations10:55 Insights & Leadership Takeaways Hosted on Acast. See acast.com/privacy for more information.
    Mehr anzeigen Weniger anzeigen
    14 Min.
  • Redefining Biomanufacturing: Himanshu Gadgil on Enzene’s Global CDMO Expansion
    Jan 5 2026

    Continuous manufacturing is reshaping biologics - and today’s guest is one of the leaders driving that shift.


    This week, in another episode of the Making It in Manufacturing Spotlight Series, we sit down with Himanshu Gadgil, PhD, CEO of Enzene. With over a decade of experience spanning scientific innovation, biologics development & manufacturing, global expansion and CDMO leadership, Himanshu shares the story behind Enzene’s rise from a small R&D biotech in India to a rapidly scaling global CIDMO with newly established US manufacturing.


    In this episode, Himanshu covers:

    - How Enzene built and evolved its first-in-class, fully-connected continuous manufacturing platform, EnzeneX - including initial failures shaped breakthrough innovation.


    - Why fully-connected continuous manufacturing™ is a cost and efficiency game-changer for biologics.


    - The regulatory and operational challenges of scaling this technology - and how Enzene approached India-to-US expansion.


    - Leadership lessons in his progression from scientist to CEO, including culture, resilience, and recognising that success depends on the combination of transformative innovation with a unique values/mission-driven approach to the way business gets done.


    - The future of biomanufacturing - from localisation and personalised production to fully automated, analytics-driven systems.


    Be sure to check out this episode to hear how Enzene is redefining what a modern CDMO can be.


    To listen to (or watch) the full episode, search "Making it in Manufacturing Enzene" on your preferred streaming platform, or click on the first link in the comments below.


    Follow ARTO

    LinkedIn: https://www.linkedin.com/company/artotalent

    Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

    Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr

    TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1

    Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

    Website: https://arto-talent.com

    Youtube: https://www.youtube.com/@life_sciences


    Himanshu Gadgil

    CEO of Enzene

    LinkedIn: https://www.linkedin.com/in/himanshu-gadgil-3326307/


    Thomas McMann

    Director - Contracts Division

    LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/


    Timestamps:

    00:10 Enzene's Vision

    04:10 Building & Scaling a Global Platform

    07:51 Enzene's Competitive Edge

    14:56 The Future of CDMO's

    21:01 Vision for Enzene's Future Growth

    Hosted on Acast. See acast.com/privacy for more information.

    Mehr anzeigen Weniger anzeigen
    22 Min.
  • Scaling a Legacy CDMO: Inside Pyramid Pharma’s Fill-Finish Expansion
    Dec 23 2025

    The CDMO everyone’s suddenly talking about, and the CEO taking it to the next level.


    This week, in another episode of the Making It in Manufacturing Spotlight Series, hosted by Thomas McMann, we sit down with Dirk T. Lange, CEO at Pyramid Pharma Services. With 30 years of experience across drug-substance and drug-product CDMOs, global operations, outsourcing leadership, and life-science services, spanning Rentschler, KBI Biopharma, Novartis, Sandoz, and more, Dirk brings a rare dual-lens perspective from both the provider and sponsor side.


    In this episode, Dirk covers:

    - A full overview of Pyramid Pharma Services, a 37-year-old CDMO with an exceptionally broad drug-product offering from clinical to commercial supply.

    - Key data behind Pyramid’s under-the-radar growth, including 15 successful FDA inspections, a strong legacy of quality, and decades of organic expansion driven by long-term customer partnerships.

    - Why they’re doubling their fill–finish capabilities, including the strategic drivers, client demand, and the transition from clinical-scale to high-speed commercial lines.

    - The operational realities of scaling, from maintaining culture to onboarding new teams, strengthening processes, and preserving execution excellence during rapid growth.

    - How Pyramid positions itself as an enabler in the supply chain, supporting customers from early development through long-term commercial supply.


    Be sure to check out this episode, a deep dive into what it really takes to scale a legacy CDMO while protecting quality, culture, and customer trust.


    To listen to (or watch) the full episode, search "Making it in Manufacturing Pyramid Pharma" on your preferred streaming platform, or click on the first link in the comments below.


    Follow ARTO

    LinkedIn: https://www.linkedin.com/company/artotalent

    Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

    Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr

    TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1

    Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

    Website: https://arto-talent.com

    Youtube: https://www.youtube.com/@life_sciences


    Dirk T. Lange

    CEO at Pyramid Pharma Services

    LinkedIn: https://www.linkedin.com/in/langedirk/


    Thomas McMann

    Director - Contracts Division

    LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/


    Timestamps:

    00:11 Pyramid Overview

    01:41 Key Data

    03:46 Doubling Fill Finish Capabilities

    05:38 Growth Challenges

    Hosted on Acast. See acast.com/privacy for more information.

    Mehr anzeigen Weniger anzeigen
    8 Min.
Noch keine Rezensionen vorhanden